As of May 22
| +0.01 / +0.63%|
The 5 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 13.00 and a low estimate of 1.20. The median estimate represents a +334.78% increase from the last price of 1.61.
The current consensus among 6 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.